Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Raised their own holding by 14%.
- 4 different insiders bought in the last 90 days.
Reasons for caution
- Similar past buys beat the S&P 500 only 45% of the time (103 cases); the typical one trailed it by 1.4%.
What happened after this filing
Insider Twins: past buys with the same traits
3+ insiders buying · no CEO or CFO · under $250K · stock up over 3 months
PRTS Jun 1, 2020 +78.0% vs S&PCRTD Dec 22, 2020 +69.9% vs S&PPRTS Sep 4, 2020 +46.1% vs S&PNYC Jul 2, 2025 -40.8% vs S&PNYC Apr 6, 2023 -38.5% vs S&PICMB Feb 20, 2020 -36.7% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Thomas J Hollister (a director) bought $105K of BBT at about $30.43 on Oct 26, 2026, reported to the SEC on Oct 26, 2026. Buys like this beat the S&P 500 45% of the time since 2020, against 46% for all insider buys. We found 3 points that make it worth a closer look and 1 reason for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the BBT alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.